Evidence map›Paper›PMID 32274591›Full record

ArticleEnvironmental monitoring and assessment2020

Age-related physicochemical differences in ZnO nanoparticles in the seawater and their bacterial interaction.

Asli Baysal, Hasan Saygin, Gul Sirin Ustabasi

Abstract read
PubMed Publisher
In one paragraph

Article in Environmental monitoring and assessment, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Asli BaysalHealth Services Vocational School of Higher Education, T. C. Istanbul Aydin University, Sefakoy Kucukcekmece, 34295, Istanbul, Turkey. aslibaysal@aydin.edu.tr.
Hasan SayginApplication and Research Center for Advanced Studies, T. C. Istanbul Aydin University, Sefakoy Kucukcekmece, 34295, Istanbul, Turkey.
Gul Sirin UstabasiHealth Services Vocational School of Higher Education, T. C. Istanbul Aydin University, Sefakoy Kucukcekmece, 34295, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To assess the fate and behavior of engineered nanoparticles in the environment, it is important to examine the physicochemical and toxicological transformation of nanoparticles as they age in seawater. In this study, we investigated how aging and seawater conditions altered the physiochemical structure of nanoparticles and affected their interactions with bacteria. For this purpose, zinc oxide nanoparticles were aged under different seawater conditions by keeping them in 1%, 10%, and 100% seawater for 1 day and 20 days. The main physicochemical parameters (surface chemistry, chemical composition, particle size, and zeta potential) and toxicity of aged nanoparticles towards gram-negative Pseudomonas aeruginosa and gram-positive Staphylococcus aureus were examined. The results indicated that aged zinc oxide nanoparticles in various concentrations of seawater changed their surface chemistry, chemical composition, particle size, and zeta potentials. Growth inhibition results were observed in that the inhibition of gram-negative (Pseudomonas aeruginosa) bacteria was higher compared with the gram-positive (Staphylococcus aureus) bacteria, and Staphylococcus aureus activated with the aged zinc oxide nanoparticles. Also, the results showed that the key biochemical factors affected by the aging and seawater concentration.

Indexed as

Metal NanoparticlesNanoparticlesZinc OxideAnti-Bacterial AgentsBacteriaEnvironmental MonitoringSeawaterWater MicrobiologyAnti-Bacterial AgentsZinc OxideBioassayBiochemical mechanismDLSEnvironmentMetal oxide nanoparticlesPathogensWeathering

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.